BSEInsider Trading / SAST2 Sept 2026 · 2 Sept 2026, 05:05 pm
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
Symbiotec Pharmalab Ltd · 544889
✦ AI SummaryRelated Party
Symbiotec Pharmalab Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Mirae Asset Mutual Fund.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Symbiotec Pharmalab Ltd - 544889 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011